{"resourceType":"MedicationRequest","id":"medrx0316","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative\u003c/b\u003e\u003c/p\u003e\u003cdiv style\u003d\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"\u003e\u003cp style\u003d\"margin-bottom: 0px\"\u003eResource \u0026quot;medrx0316\u0026quot; \u003c/p\u003e\u003c/div\u003e\u003cp\u003e\u003cb\u003eidentifier\u003c/b\u003e: id: 12345689 (OFFICIAL)\u003c/p\u003e\u003cp\u003e\u003cb\u003einstantiatesUri\u003c/b\u003e: \u003ca href\u003d\"http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf\"\u003ehttp://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf\u003c/a\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003estatus\u003c/b\u003e: completed\u003c/p\u003e\u003cp\u003e\u003cb\u003eintent\u003c/b\u003e: order\u003c/p\u003e\u003cp\u003e\u003cb\u003esubject\u003c/b\u003e: \u003ca href\u003d\"patient-pat1.html\"\u003ePatient/pat1: Donald Duck\u003c/a\u003e \u0026quot;Donald DUCK\u0026quot;\u003c/p\u003e\u003cp\u003e\u003cb\u003eencounter\u003c/b\u003e: \u003ca href\u003d\"encounter-f001.html\"\u003eEncounter/f001: encounter who leads to this prescription\u003c/a\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eauthoredOn\u003c/b\u003e: 2015-01-15\u003c/p\u003e\u003cp\u003e\u003cb\u003erequester\u003c/b\u003e: \u003ca href\u003d\"practitioner-f007.html\"\u003ePractitioner/f007: Patrick Pump\u003c/a\u003e \u0026quot;Simone HEPS\u0026quot;\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edose\u003c/b\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/div\u003e"},"contained":[{"resourceType":"Medication","id":"med0306","code":{"coding":[{"system":"http://hl7.org/fhir/sid/ndc","code":"51144-050-01","display":"Adcetris"}]},"doseForm":{"coding":[{"system":"http://snomed.info/sct","code":"421637006","display":"Lyophilized powder for injectable solution (qualifier value) "}]},"batch":{"lotNumber":"12345","expirationDate":"2019-10-31"}}],"identifier":[{"use":"official","system":"http://www.bmc.nl/portal/prescriptions","value":"12345689"}],"instantiatesUri":["http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf"],"status":"completed","intent":"order","medication":{"reference":{"reference":"#med0306"}},"subject":{"reference":"Patient/pat1","display":"Donald Duck"},"encounter":{"reference":"Encounter/f001","display":"encounter who leads to this prescription"},"authoredOn":"2015-01-15","requester":{"reference":"Practitioner/f007","display":"Patrick Pump"},"dose":{"dosageInstruction":[{"sequence":1,"text":"1.8 mg/kg IV infusion over 20 minutes every 3 weeks for 16 cycles","timing":{"repeat":{"count":16,"frequency":1,"period":3,"periodUnit":"wk"}},"route":{"coding":[{"system":"http://snomed.info/sct","code":"255560000","display":"Intravenous"}]},"doseAndRate":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/dose-rate-type","code":"ordered","display":"Ordered"}]},"doseQuantity":{"value":1.8,"unit":"mg/kg","system":"http://unitsofmeasure.org","code":"mg/kg"},"rateRatio":{"numerator":{"value":1.8,"system":"http://unitsofmeasure.org","code":"mg/kg"},"denominator":{"value":20,"system":"http://unitsofmeasure.org","code":"min"}}}],"maxDosePerLifetime":{"value":400,"unit":"mg","system":"http://unitsofmeasure.org","code":"mg"}}]}}